RxDoctor Payments Data

Chiazo Amene, MD

Neurological Surgery · Fort Worth, TXNPI 1245435056

Payments from drug & device makers

$2,253in general payments, 2019–2025

Across 27 payments — averaging $83.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • CTL Medical Corporation$438
  • Medtronic$399
  • Johnson & Johnson$381
  • Implanet America, Inc.$254
  • Nanohive Medical LLC$253
  • Globus Medical$183
  • plus $345 from 4 others

What the payments were for

  • Travel & lodging$1346%
  • Food & beverage$2,11994%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
22
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
CTL Medical Corporation5$438
Medtronic(2 entities)4$399
Johnson & Johnson5$381
Implanet America, Inc.1$254
Nanohive Medical LLC3$253
Globus Medical2$183
Stryker4$153
Spinesource, Inc.1$87
Surgalign Spine Technologies, Inc.1$78
Integra Lifesciences Corporation1$26

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,253 in reported general payments places this provider in the 35th percentile of 582 neurological surgery providers in Texas.

See all neurological surgery providers in Texas

Medicare billing

Part B allowed, 2024
$19,652
Medicare patients
21
Services billed
47

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gabapentin11$150

Paid to pharmacies, not to this prescriber.

Other neurological surgery in Fort Worth

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →